Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice-Reference-Cited by-同舟云学术

Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice

Published:2018-12-13 Issue: Volume:24 Page:9045-9053
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Cheng Yinzhi¹,Li Shuai¹,Wang Muzi¹,Cheng Cheng¹,Liu Rongyu¹

Affiliation:

1. Department of Pulmonary, First Affiliated Hospital of Medical University of Anhui, Anhui Geriatrics Research Institute, Hefei, Anhui, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular senescence-Related genes define the immune microenvironment and molecular characteristics in severe asthma patients;Gene;2024-08

2. Elafibranor PPARα/δ Dual Agonist Ameliorates Ovalbumin-Induced Allergic Asthma;Biomolecules & Therapeutics;2024-06-05

3. Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders;Cell Communication and Signaling;2024-02-15

4. Pyroptosis and respiratory diseases: A review of current knowledge;Frontiers in Immunology;2022-09-30

5. Network pharmacology and in vivo experiments reveal the pharmacological effects and molecular mechanisms of Simiao Powder in prevention and treatment for gout;BMC Complementary Medicine and Therapies;2022-06-07